Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
6
Mins
19 Jun 2025
Timing of Anticoagulation in Variceal Bleeding with Portal Vein Thrombosis
Portal vein thrombus (PVT) is characterised by narrowing or blockage of the portal vein by a blood clot. Obstruction may be complete…
3
Mins
19 Jun 2025
MASH Redefined: Insights from the EASL Congress 2025
THE EUROPEAN Association for the Study of the Liver (EASL) Congress 2025, Amsterdam, the Netherlands, placed patients and…
1
Mins
19 Jun 2025
Mitigation of Immune Dysfunction in Patients with Hepatitis B after siRNA Treatment
A chronic hepatitis B (CHB) infection is characterised by host immune dysfunction related to a high viral antigen load. The restoration of…
2
Mins
19 Jun 2025
Albumin Therapy for Decompensated Cirrhosis: EASL Congress 2025
THE MANAGEMENT of decompensated cirrhosis remains a formidable challenge in hepatology, owing to its multifaceted complications…
2
Mins
19 Jun 2025
Hepatocyte–Neutrophil Interaction Is Key in the Pathogenesis of Alcohol-Associated Hepatitis
Alcohol-associated hepatitis (AH) is the most severe form of alcohol-related liver disease (ALD), which is characterised by an impairment…
5
Mins
19 Jun 2025
EASL 2025 Abstract Highlights
The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver (EASL) Congress…
6
Mins
19 Jun 2025
Pregnancy and Liver Disease: A Multidisciplinary Challenge
AT THIS year’s European Association for the Study of the Liver (EASL) Congress 2025, held in Amsterdam, the Netherlands…
4
Mins
19 Jun 2025
EAACI 2025 Interview: María Torres
The focus of the EAACI Congress 2025 program is planetary health and a sustainable future. We anticipate that our Congress in Glasgow, UK…
18 Jun 2025
Combination Therapy Improves Survival in Liver Cancer
Results showed that patients receiving the combination therapy experienced a median progression-free survival of 5.8 months, compared with 4.0 months.
18 Jun 2025
Edoxaban Suitable for Stroke Prevention in Over-75s with AF?
Edoxaban and rivaroxaban show best balance of efficacy and safety in elderly patients with atrial fibrillation.
←
1
2
3
…
13
14
15
16
17
18
19
…
1,161
1,162
1,163
→
We’ve noticed you’re accessing
from
North/South America.
View
View